DYN — DYNE THERAPEUTICS INC

Ownership history in Point72 (DIFC) Ltd  ·  4 quarters on record

This page tracks every 13F SEC filing in which Point72 (DIFC) Ltd reported a position in DYNE THERAPEUTICS INC (DYN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2024 Q4)
Avg. % of fund
0.0%
First filed
2024 Q3
Last filed
2025 Q2
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q2 ADDED 7,451 +82 +1.1% 0.00% $71K $9.52
2025 Q1 ADDED 7,369 +949 +14.8% 0.00% $77K $10.46
2024 Q4 ADDED 6,420 +5,428 +547.2% 0.01% $151K $23.56
2024 Q3 INITIATED 992 — — 0.00% $36K $35.92
% of Fund (quarterly)    DYN price (monthly, adj. close)

Other funds also holding DYN

As of 2025 Q4 — sorted by position size

Atlas Venture Life Science Advisors, LLC 3Y 20.64% FCPM III SERVICES B.V. 14.01% Saturn V Capital Management LP 3Y 6.42% Palo Alto Investors LP 3Y 7Y 4.01% Vivo Capital, LLC 3Y 7Y 3.31% MPM BioImpact LLC 3Y 3.15% TCG Crossover Management, LLC 3Y 2.99% STEMPOINT CAPITAL LP 2.8% VR Adviser, LLC 3Y 2.1% Siren, L.L.C. 2.04%
← Back to Point72 (DIFC) Ltd Holdings